Funding for this research was provided by:
Text and Data Mining valid from 2018-02-04
Received: 30 November 2017
Accepted: 25 January 2018
First Online: 4 February 2018
Compliance with ethical standards
: RC and RH are inventors of the patent-protected HepaRG-based AMC-Bioartificial liver that is currently being commercialized through the university spin-off company Hep-Art Medical Devices B.V of which RC is unsalaried Chief Scientific Officer. RH was previously employed part-time by Hep-Art Medical Devices B.V.The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.